Fact CheckerSign in

NCT06842745RecruitingPhase 2

Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia

Personalized Transcranial Magnetic Stimulation and Constraint Induced Language Therapy to Treat Mild Post-Stroke Aphasia

Source: ClinicalTrials.gov · Last updated 5 Mar 2026

Brief summary (registry, in English)

The goal of this clinical trial is to determine if Transcranial Magnetic Stimulation (TMS) combined with Speech-Language Therapy (SLT) is an effective treatment for mild aphasia in persons with chronic stroke. The main questions this study aims to answer are: 1. Can TMS combined with SLT improve conversational speech and comprehension? 2. Can we identify specific behavioral and biological characteristics that would benefit most from the TMS and SLT treatment? Researchers will compare real TMS to sham (fake) TMS to see whether TMS can treat post-stroke mild aphasia. Participants will: * Complete a screening and medical intake to determine eligibility * Undergo a MRI * Participate in 10 consecutive sessions (Monday-Friday) of TMS and SLT treatment * Complete follow-up assessments 2 and 4 months after treatment

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
24 (estimated)
First submitted
18 Feb 2025
Start date
11 Feb 2025
Primary completion date
31 Aug 2026
Lead sponsor
University of Pennsylvania
Diseases
Stroke
NCT number
NCT06842745

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 24
  • From 11 Feb 2025 to the primary completion date, 31 Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Other neurological disorders, beside stroke (i.e. dementia, traumatic brain injury, multiple sclerosis)
  • Active psychiatric disorders (i.e. bipolar disorder, schizophrenia)
  • Pacemaker or cardiac defibrillator
  • Epilepsy, or seizure in the past 6 months

Other

  • Ongoing substance or alcohol abuse
  • Diagnosis of tinnitus

Who the study is looking for

  • Left Hemisphere stroke
  • Stroke occurred more than 6 months ago
  • Mild Aphasia (WAB AQ score \> 85)
  • Proficient in English

Age in the registry: 40 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Pennsylvania
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.